Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sensorium Therapeutics logo — Thriving by nature.

Sensorium Therapeutics

Thriving by nature.

Founded 2021 United States Boston, United States 26 employees Series A Total: $30.00M Health Care, Health and Wellness

General Information

Company Name Sensorium Therapeutics
Founded Year 2021
Location United States Boston, United States +1
Founders / Decision Makers
Team member
Employees 26
Industries Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Sensorium Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sensorium Therapeutics

Sensorium Therapeutics is a biotechnology company that was founded in 2021 by a team of world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University. The company aims to develop nature-derived psychoactive medicines for mental health by leveraging cutting-edge chemistry, neuroscience, and machine learning. Sensorium's groundbreaking Biodynamic Discovery Platform is inspired by the real-world human benefits of plants and fungi, and it aims to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines. The company recently secured a $30.00M Series A investment on 04 October 2022 from a group of investors including Route 66 Ventures, Santé Ventures, CU Healthcare Innovation Fund, Iter Investments, Ocama Partners, re.Mind Capital, WPSS.bio, and Palo Santo. With its innovative approach and strong backing, Sensorium Therapeutics is well-positioned to make a significant impact in the health care industry with its nature-inspired approach to mental health. Visit sensorium.bio to learn more about the company's mission and vision.

Taxonomy: Neuroscience, Mental health, Psychoactive medicines, Nature-derived, Chemistry, Machine learning, Research, Clinical, Harvard University, Massachusetts General Hospital, Biodynamic Discovery Platform

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		04 Oct 2022

Sensorium Therapeutics Alternatives & Competitors

Sensorium Therapeutics vs
Kalgera
Kalgera United Kingdom

Safeguarding financial lives

Series Unknown
3 employees
Financial Services, Internet
Compare Sensorium Therapeutics vs Kalgera
Sensorium Therapeutics vs
1200 Pharma
1200 Pharma United States

We leverage our breakthrough chemistry, cutting edge computation & data-rich models to accelerate dr...

Series Unknown
32 employees
Biotechnology, Health Care
Compare Sensorium Therapeutics vs 1200 Pharma
Sensorium Therapeutics vs
Matchpoint Therapeutics
Matchpoint Therapeutics

Acing the future of covalent medicines

Series A
32 employees
Biotechnology, Pharmaceutical
Compare Sensorium Therapeutics vs Matchpoint Therapeutics

FAQ About Sensorium Therapeutics

Thriving by nature.
Sensorium Therapeutics was founded in 2021.
Sensorium Therapeutics is headquartered in Boston, United States.
Sensorium Therapeutics operates in the following industries: Health Care, Health and Wellness.
Sensorium Therapeutics has approximately 26 employees.
Sensorium Therapeutics has completed 1 funding round, raising a total of $30.00M. The latest funding stage is Series A.
Top alternatives and competitors to Sensorium Therapeutics include Kalgera, 1200 Pharma, Matchpoint Therapeutics, Vilya, Solvemed Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sensorium Therapeutics and Kalgera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sensorium Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes